基于犹他州监测、流行病学和最终结果数据(1973-2011年),多原发黑色素瘤与单原发黑色素瘤患者生存率相似
研究比较多原发黑色素瘤(MPM)与单原发黑色素瘤(SPM)患者的生存,从犹他州SEER登记库1973-2011年14138例记录中为每例MPM随机匹配1例存活至少至MPM第一与第二诊断间隔的SPM对照。生存曲线(两组各887例)显示MPM有显著生存劣势(卡方39.29,P<.001),但多因素Cox模型显示无显著生存差异(风险比1.07,P=.55);限于侵袭性黑色素瘤的多因素分析亦无显著差异(风险比0.99,P=.96)。结论为MPM与SPM患者生存时间相似。
要点
- 匹配后生存曲线显示MPM患者生存显著差于SPM(卡方39.29,P<.001)。
- 多因素Cox模型显示MPM与SPM无显著生存差异(风险比1.07,P=.55)。
- 限于侵袭性黑色素瘤时亦无显著生存差异(风险比0.99,P=.96)。
核心结论
- 多原发黑色素瘤患者与单原发黑色素瘤患者生存时间相似。
研究设计与样本
- 回顾性队列研究,数据来自犹他州监测、流行病学和最终结果(SEER)登记库1973-2011年诊断或治疗的14138例黑色素瘤患者记录。
- 为每例MPM患者从SPM队列随机匹配1例对照,限制对照存活至少等于匹配MPM患者第一与第二诊断之间的间隔。
主要发现
- 无协变量生存曲线(MPM与SPM组各887例)显示MPM患者有显著生存劣势(卡方39.29,P<.001)。
- 多因素Cox比例风险模型显示无显著生存差异(风险比1.07,P=.55)。
- 限于侵袭性黑色素瘤的多因素分析亦显示无显著生存差异(风险比0.99,P=.96)。
局限性
- 并非所有患者均有Breslow深度、溃疡状态和具体死因数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Survival data are mixed comparing patients with multiple primary melanomas (MPM) to those with single primary melanomas (SPM). OBJECTIVES: We compared MPM versus SPM patient survival using a matching method that avoids potential biases associated with other analytic approaches. METHODS: Records of 14,138 individuals obtained from the Surveillance, Epidemiology, and End Results registry of all melanomas diagnosed or treated in Utah between 1973 and 2011 were reviewed. A single matched control patient was selected randomly from the SPM cohort for each MPM patient, with the restriction that they survived at least as long as the interval between the first and second diagnoses for the matched MPM patient. RESULTS: Survival curves (n = 887 for both MPM and SPM groups) without covariates showed a significant survival disadvantage for MPM patients (chi-squared 39.29, P < .001). However, a multivariate Cox proportional hazards model showed no significant survival difference (hazard ratio 1.07, P = .55). Restricting the multivariate analysis to invasive melanomas also showed no significant survival difference (hazard ratio 0.99, P = .96). LIMITATIONS: Breslow depth, ulceration status, and specific cause of death were not available for all patients. CONCLUSIONS: Patients with MPM had similar survival times as patients with SPM.
引用
- Grossman D, Farnham JM, Hyngstrom J, et al. Similar survival of patients with multiple versus single primary melanomas based on Utah Surveillance, Epidemiology, and End Results data (1973-2011). J Am Acad Dermatol. 2018. PMID: 29499295. doi:10.1016/j.jaad.2018.02.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。